Erdogan-Trinkaus Ipek

Directeur Commercial

OFFICER

US·SEC (Form 4)

Eton Pharmaceuticals, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Erdogan-Trinkaus Ipek, Directeur Commercial. Officer active across 1 companies, notably Eton Pharmaceuticals, Inc.. Cumulatively, 2 reports have been recorded. The latest transaction was disclosed on 12 December 2025 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations2 total

Executives●Retenue fiscaleEEton Pharmaceuticals, Inc.19SEC

E

Erdogan-Trinkaus IpekChief Commercial Officer

US$1,22485 shares@ US$14.39590.0001% mcap100.0% of flow

Common Stock

SEC:0001437749-25-037747·12 Dec 2025

SEC ↗

Executives●Retenue fiscaleEEton Pharmaceuticals, Inc.18SEC

E

Erdogan-Trinkaus IpekChief Commercial Officer

€1,22485 shares@ €14.39590.0001% mcap50.0% of flow

Common Stock

SEC:0001437749-25-037747:0·12 Dec 2025

SEC ↗

2 of 2 declarations

KD

Krempa David

Chief Business Officer

Erdogan-Trinkaus Ipek

Similar companies

Related executives